• A Window of Opportunity for Treating Patients with Cirrhosis

A Window of Opportunity for Treating Patients with Cirrhosis

Despite the ability of nonselective β blockers (NSBBs) to reduce portal pressure and lower the risk of variceal hemorrhage in patients with cirrhosis, these drugs have detrimental effects on those who have developed spontaneous bacterial peritonitis, researchers show in the June issue of Gastroenterology. Variceal hemorrhage, the most common lethal complication of

Read more